G. J. McKenna, J. F. Trotter, E. Klintmalm, N. Onaca, R. Ruiz, L. W. Jennings, M. Neri, J. G. O’Leary, G. L. Davis, M. F. Levy, R. M. Goldstein and G. B. Klintmalm Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression American Journal of Transplantation 11
Article first published online: 3 OCT 2011 | DOI: 10.1111/j.1600-6143.2011.03767.x
Sirolimus use as part of the primary immunosuppression in liver transplantation limits hepatitis C virus fibrosis progression in the first two years posttransplant, as seen on annual protocolized liver biopsies. See editorial by Alexander on page 2273.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field